Comment on “Understanding Atomoxetine Exposure Variability in Children and Adolescents with ADHD through Population Pharmacokinetics”

Documenti analoghi

• Understanding Atomoxetine Exposure Variability in Children and Adolescents With ADHD Through Population Pharmacokinetics
  di: Kevin. V. Tobin, et al.
  Pubblicazione: (2026)
• Comment on “Exploration of a Multimodal Machine Learning Model Integrating Ultrasound and Clinical Indicators for the Diagnosis of Diabetic Peripheral Neuropathy”
  di: Madhuri Tribhuvan, et al.
  Pubblicazione: (2026)
• Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention‐Deficit /Hyperactivity Disorder
  di: Shen Cheng, et al.
  Pubblicazione: (2024)
• Correction to “Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention‐Deficit/Hyperactivity Disorder”
  Pubblicazione: (2025)
• Comment on “Exploring Loneliness in Family Caregiver–Care Recipient Dyads: Implications for Caregiver Burden”
  di: Madhuri Tribhuvan, et al.
  Pubblicazione: (2026)